STOCKHOLM, SWEDEN – July 5, 2023. Karolinska Development AB today announces that its portfolio company Umecrine Cognition has presented results from a study on a preclinical model of.
MIL-OSI: Karolinska Development s portfolio company Umecrine Cognition presents data on golexanolone in a preclinical model of Parkinson s disease foreignaffairs.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from foreignaffairs.co.nz Daily Mail and Mail on Sunday newspapers.